Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 232

1.

Praxistipps zu Diagnostik und Therapie der Lungenentzündung.

Bogner JR.

MMW Fortschr Med. 2020 Mar;162(4):38-39. doi: 10.1007/s15006-020-0215-3. Review. German. No abstract available.

PMID:
32124348
2.

Frischen Sie Ihr Wissen zu Neuroinfektionen auf!

Bogner JR.

MMW Fortschr Med. 2020 Feb;162(3):36-37. doi: 10.1007/s15006-020-0157-9. Review. German. No abstract available.

PMID:
32072529
3.

"My Friend with HIV Remains a Friend": HIV/AIDS Stigma Reduction through Education in Secondary Schools-A Pilot Project in Buea, Cameroon.

Jacobi CA, Atanga PN, Bin LK, Fru AJC, Eppel G, Mbome VN, Etonde HEM, Bogner JR, Malfertheiner P.

J Int Assoc Provid AIDS Care. 2020 Jan-Dec;19:2325958219900713. doi: 10.1177/2325958219900713.

4.

Coronavirus: Stehen wir am Beginn einer neuen Pandemie?

Bogner JR.

MMW Fortschr Med. 2020 Feb;162(2):8-10. doi: 10.1007/s15006-020-0080-0. German. No abstract available.

PMID:
32016738
Free PMC Article
5.

SERINC5 Is an Unconventional HIV Restriction Factor That Is Upregulated during Myeloid Cell Differentiation.

Zutz A, Schölz C, Schneider S, Pierini V, Münchhoff M, Sutter K, Wittmann G, Dittmer U, Draenert R, Bogner JR, Fackler OT, Keppler OT.

J Innate Immun. 2020 Jan 14:1-11. doi: 10.1159/000504888. [Epub ahead of print]

6.

Welcome to our new Section Editors in INFECTION.

Bogner JR.

Infection. 2020 Feb;48(1):1-2. doi: 10.1007/s15010-019-01387-2. No abstract available.

PMID:
31919762
7.

[Human immunodeficiency virus infection in the elderly].

Bogner JR.

Z Gerontol Geriatr. 2020 Mar;53(2):179-191. doi: 10.1007/s00391-019-01669-2. Epub 2019 Dec 12. German.

PMID:
31832770
8.

Bei Atemnot sicher wissen, was zu tun ist.

Bogner JR.

MMW Fortschr Med. 2019 Nov;161(20):42. doi: 10.1007/s15006-019-1153-9. Review. German. No abstract available.

PMID:
31773601
9.

Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study).

Schäfer G, Hoffmann C, Arasteh K, Schürmann D, Stephan C, Jensen B, Stoll M, Bogner JR, Faetkenheuer G, Rockstroh J, Klinker H, Härter G, Stöhr A, Degen O, Freiwald E, Hüfner A, Jordan S, Schulze Zur Wiesch J, Addo M, Lohse AW, van Lunzen J, Schmiedel S; IDEAL study group.

AIDS Res Ther. 2019 Nov 15;16(1):34. doi: 10.1186/s12981-019-0250-2.

10.

Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment.

Mocroft A, Lundgren J, Gerstoft J, Rasmussen LD, Bhagani S, Aho I, Pradier C, Bogner JR, Mussini C, Uberti Foppa C, Maltez F, Laguno M, Wandeler G, Falconer K, Trofimova T, Borodulina E, Jevtovic D, Bakowska E, Kase K, Kyselyova G, Haubrich R, Rockstroh JK, Peters L; EuroSIDA Study .

Clin Infect Dis. 2019 Jul 2. pii: ciz601. doi: 10.1093/cid/ciz601. [Epub ahead of print]

PMID:
31504296
11.

Efficacy and safety of dolutegravir-rilpivirine for maintenance of virological suppression in adults with HIV-1: 100-week data from the randomised, open-label, phase 3 SWORD-1 and SWORD-2 studies.

Aboud M, Orkin C, Podzamczer D, Bogner JR, Baker D, Khuong-Josses MA, Parks D, Angelis K, Kahl LP, Blair EA, Adkison K, Underwood M, Matthews JE, Wynne B, Vandermeulen K, Gartland M, Smith K.

Lancet HIV. 2019 Sep;6(9):e576-e587. doi: 10.1016/S2352-3018(19)30149-3. Epub 2019 Jul 12.

PMID:
31307948
12.

Immer wieder Neues in Therapie und Prophylaxe der HIV-Infektion.

Bogner JR.

MMW Fortschr Med. 2019 Jun;161(Suppl 2):3. doi: 10.1007/s15006-019-0565-x. Review. German. No abstract available.

PMID:
31175603
13.

Blick in den Mund offenbart HIV-Infektion.

Bogner JR.

MMW Fortschr Med. 2019 Jun;161(Suppl 2):7. doi: 10.1007/s15006-019-0567-8. German. No abstract available.

PMID:
31175601
14.

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.

Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, Corbelli GM, Estrada V, Geretti AM, Beloukas A, Raben D, Coll P, Antinori A, Nwokolo N, Rieger A, Prins JM, Blaxhult A, Weber R, Van Eeden A, Brockmeyer NH, Clarke A, Del Romero Guerrero J, Raffi F, Bogner JR, Wandeler G, Gerstoft J, Gutiérrez F, Brinkman K, Kitchen M, Ostergaard L, Leon A, Ristola M, Jessen H, Stellbrink HJ, Phillips AN, Lundgren J; PARTNER Study Group.

Lancet. 2019 Jun 15;393(10189):2428-2438. doi: 10.1016/S0140-6736(19)30418-0. Epub 2019 May 2.

15.

Hot topics and cold lecture halls: the ECCMID 2019.

Bogner JR.

Infection. 2019 Jun;47(3):337-339. doi: 10.1007/s15010-019-01310-9. No abstract available.

PMID:
31025217
16.

Sepsis: a frequent topic in a new Editorial Section in INFECTION.

Bogner JR.

Infection. 2019 Feb;47(1):1-2. doi: 10.1007/s15010-019-01272-y. No abstract available.

PMID:
30689159
17.

Das ABC der Antibiotikatherapie.

Bogner JR.

MMW Fortschr Med. 2019 Jan;161(1):34. doi: 10.1007/s15006-019-0064-0. Review. German. No abstract available.

PMID:
30671828
18.

[Differentiation of viral and bacterial infections in general practice and emergency department. Are there new tests?]

Bogner JR, Karwat MF.

MMW Fortschr Med. 2019 Jan;161(1):35-40. doi: 10.1007/s15006-019-0065-z. Review. German. No abstract available.

PMID:
30671827
20.

[HIV - Innovation of diagnosis and treatment during the last decade].

Bogner JR.

MMW Fortschr Med. 2018 Nov;160(Suppl 3):76-80. doi: 10.1007/s15006-018-1129-1. Review. German. No abstract available.

PMID:
30421190
21.

Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1-infected adults: Week 24 primary analysis from a randomized Phase IIb trial.

Morales-Ramirez J, Bogner JR, Molina JM, Lombaard J, Dicker IB, Stock DA, DeGrosky M, Gartland M, Pene Dumitrescu T, Min S, Llamoso C, Joshi SR, Lataillade M.

PLoS One. 2018 Oct 23;13(10):e0205368. doi: 10.1371/journal.pone.0205368. eCollection 2018.

22.

Resignment: Infection is grateful to Prof. Alexander von Graevenitz.

Bogner JR.

Infection. 2018 Dec;46(6):749-750. doi: 10.1007/s15010-018-1228-z. No abstract available.

PMID:
30311180
23.
24.

Er trägt ein HIV-Warnzeichen auf der Stirn.

Bogner JR.

MMW Fortschr Med. 2018 Jun;160(Suppl 2):7. doi: 10.1007/s15006-018-0637-3. German. No abstract available.

PMID:
29943344
25.

[Long-Term Non-Progressor].

Ibarra G, Seybold U, Bogner JR.

MMW Fortschr Med. 2018 Jun;160(Suppl 2):39-41. doi: 10.1007/s15006-018-0657-z. Review. German. No abstract available.

PMID:
29943328
26.

Infektiologie für den Hausarzt.

Bogner JR.

MMW Fortschr Med. 2018 May;160(10):36-37. doi: 10.1007/s15006-018-0579-9. Review. German. No abstract available.

PMID:
29855905
27.

[Erysipelas].

Seybold U, Stubbe H, Draenert R, Bogner JR.

MMW Fortschr Med. 2018 May;160(10):37-40. doi: 10.1007/s15006-018-0580-3. Review. German. No abstract available.

PMID:
29855904
28.

[Mononucleosis: a disease with three different etiologies].

Stemberger M, Jung C, Bogner JR.

MMW Fortschr Med. 2018 May;160(10):44-48. doi: 10.1007/s15006-018-0582-1. Review. German. No abstract available.

PMID:
29855902
29.

Treatment Intensification in HIV-Infected Patients Is Associated With Reduced Frequencies of Regulatory T Cells.

Grützner EM, Hoffmann T, Wolf E, Gersbacher E, Neizert A, Stirner R, Pauli R, Ulmer A, Brust J, Bogner JR, Jaeger H, Draenert R.

Front Immunol. 2018 Apr 30;9:811. doi: 10.3389/fimmu.2018.00811. eCollection 2018.

30.

The field is moving on: new diagnostic and therapeutic tools presented at the 28th ECCMID 2018.

Bogner JR.

Infection. 2018 Jun;46(3):289-291. doi: 10.1007/s15010-018-1142-4. No abstract available.

PMID:
29736856
31.

Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study.

Schommers P, Gillor D, Hentrich M, Wyen C, Wolf T, Oette M, Zoufaly A, Wasmuth JC, Bogner JR, Müller M, Esser S, Schleicher A, Jensen B, Stoehr A, Behrens G, Schultze A, Siehl J, Thoden J, Taylor N, Hoffmann C.

Haematologica. 2018 May;103(5):857-864. doi: 10.3324/haematol.2017.180893. Epub 2018 Feb 8.

32.

The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people.

Shepherd L, Borges ÁH, Harvey R, Bower M, Grulich A, Silverberg M, Weber J, Ristola M, Viard JP, Bogner JR, Gargalianos-Kakolyris P, Mussini C, Mansinho K, Yust I, Paduta D, Jilich D, Smiatacz T, Radoi R, Tomazic J, Plomgaard P, Frikke-Schmidt R, Lundgren J, Mocroft A; EuroSIDA in EuroCOORD.

HIV Med. 2018 Feb;19(2):90-101. doi: 10.1111/hiv.12546. Epub 2017 Aug 31.

33.

Kutane Warnlampe für den HIV-Test.

Bogner JR.

MMW Fortschr Med. 2017 Jun;159(Suppl 2):7. doi: 10.1007/s15006-017-9723-1. German. No abstract available.

PMID:
28597277
34.

[Finally the therapy worked].

Ibarra G, Seybold U, Bogner JR.

MMW Fortschr Med. 2017 Jun;159(Suppl 2):31-33. doi: 10.1007/s15006-017-9732-0. Review. German. No abstract available.

PMID:
28597268
35.

Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial.

Baker JV, Sharma S, Achhra AC, Bernardino JI, Bogner JR, Duprez D, Emery S, Gazzard B, Gordin J, Grandits G, Phillips AN, Schwarze S, Soliman EZ, Spector SA, Tambussi G, Lundgren J; INSIGHT (International Network for Strategic Initiatives in Global HIV Trials) START (Strategic Timing of Antiretroviral Treatment) Study Group.

J Am Heart Assoc. 2017 May 22;6(5). pii: e004987. doi: 10.1161/JAHA.116.004987.

36.

Scaring and encouraging news on diagnosis, spreading, and therapy of resistant organisms: the ECCMID 2017 in Vienna.

Bogner JR.

Infection. 2017 Jun;45(3):251-253. doi: 10.1007/s15010-017-1021-4. No abstract available.

PMID:
28484992
37.

The "Choosing Wisely" initiative in infectious diseases.

Lehmann C, Berner R, Bogner JR, Cornely OA, de With K, Herold S, Kern WV, Lemmen S, Pletz MW, Ruf B, Salzberger B, Stellbrink HJ, Suttorp N, Ullmann AJ, Fätkenheuer G, Jung N.

Infection. 2017 Jun;45(3):263-268. doi: 10.1007/s15010-017-0997-0. Epub 2017 Mar 13. Review.

PMID:
28290130
38.

Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in Germany.

Schwarze-Zander C, Draenert R, Lehmann C, Stecher M, Boesecke C, Sammet S, Wasmuth JC, Seybold U, Gillor D, Wieland U, Kümmerle T, Strassburg CP, Mankertz A, Eis-Hübinger AM, Jäger G, Fätkenheuer G, Bogner JR, Rockstroh JK, Vehreschild JJ.

Epidemiol Infect. 2017 Jan;145(2):236-244. doi: 10.1017/S095026881600217X. Epub 2016 Oct 26.

PMID:
27780480
39.

[This far it can go without HIV therapy!].

Bogner JR, Steinert D, Coppenrath E.

MMW Fortschr Med. 2016 Jun 9;158 Suppl 1:7. doi: 10.1007/s15006-016-8308-8. German. No abstract available.

PMID:
27259886
40.

Medium-grade tubular proteinuria is common in HIV-positive patients and specifically associated with exposure to tenofovir disoproxil Fumarate.

Zeder AJ, Hilge R, Schrader S, Bogner JR, Seybold U.

Infection. 2016 Oct;44(5):641-9. doi: 10.1007/s15010-016-0911-1. Epub 2016 Jun 2.

PMID:
27256076
41.

Accelerated CD4+ cell count decline in untreated HIV-1 patients points toward increasing virulence over the course of the epidemic.

Brey FL, Seybold U, Kollan C, Bogner JR; ClinSurv-HIV Study Group.

AIDS. 2016 Jul 31;30(12):1995-7. doi: 10.1097/QAD.0000000000001165.

PMID:
27191976
42.

PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxis.

Fätkenheuer G, Jessen H, Stoehr A, Jung N, Jessen AB, Kümmerle T, Berger M, Bogner JR, Spinner CD, Stephan C, Degen O, Vogelmann R, Spornraft-Ragaller P, Schnaitmann E, Jensen B, Ulmer A, Kittner JM, Härter G, Malfertheiner P, Rockstroh J, Knecht G, Scholten S, Harrer T, Kern WV, Salzberger B, Schürmann D, Ranneberg B.

HIV Med. 2016 Jun;17(6):453-9. doi: 10.1111/hiv.12363. Epub 2016 May 11.

43.

Blue sky and some shadows: new antibiotics and new superbugs : The ECCMID 2016 in Amsterdam.

Bogner JR.

Infection. 2016 Jun;44(3):271-2. doi: 10.1007/s15010-016-0898-7. No abstract available.

PMID:
27125508
44.

Kinetics of human myeloid-derived suppressor cells after blood draw.

Grützner E, Stirner R, Arenz L, Athanasoulia AP, Schrödl K, Berking C, Bogner JR, Draenert R.

J Transl Med. 2016 Jan 6;14:2. doi: 10.1186/s12967-015-0755-y.

45.

Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial.

Lalezari JP, Latiff GH, Brinson C, Echevarría J, Treviño-Pérez S, Bogner JR, Thompson M, Fourie J, Sussmann Pena OA, Mendo Urbina FC, Martins M, Diaconescu IG, Stock DA, Joshi SR, Hanna GJ, Lataillade M; AI438011 study team.

Lancet HIV. 2015 Oct;2(10):e427-37. doi: 10.1016/S2352-3018(15)00177-0. Epub 2015 Sep 1.

PMID:
26423650
46.

Treatment strategies for treatment naïve HIV patients in Germany: evidence from claims data.

Mahlich J, Bogner JR, Tomeczkowski J, Stoll M.

Springerplus. 2015 Jul 1;4:306. doi: 10.1186/s40064-015-1099-z. eCollection 2015.

47.

Dieses Exanthem bedeutet nichts Gutes.

Bogner JR.

MMW Fortschr Med. 2015 Jun;157 Suppl 2:5. doi: 10.1007/s15006-015-3154-7. German. No abstract available.

PMID:
26048110
48.

[Practice guidance for the rational use of diagnostic tests for borreliosis].

Bogner JR, Füeßl HS.

MMW Fortschr Med. 2015 Mar 26;157 Suppl 1:36-41. doi: 10.1007/s15006-015-2718-x. Review. German. No abstract available.

PMID:
26012987
49.

From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany.

Schmidt D, Kollan C, Stoll M, Stellbrink HJ, Plettenberg A, Fätkenheuer G, Bergmann F, Bogner JR, van Lunzen J, Rockstroh J, Esser S, Jensen BE, Horst HA, Fritzsche C, Kühne A, an der Heiden M, Hamouda O, Bartmeyer B; ClinSurv Study Group.

BMC Public Health. 2015 Mar 17;15:252. doi: 10.1186/s12889-015-1598-4.

50.

Transmission risk behaviour at enrolment in participants in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

Rodger AJ, Lampe FC, Grulich AE, Fisher M, Friedland G, Phanuphak N, Bogner JR, Pereira LC, Rietmeijer C, Burman W, Phillips AN; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group.

HIV Med. 2015 Apr;16 Suppl 1:64-76. doi: 10.1111/hiv.12235.

Supplemental Content

Loading ...
Support Center